| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$29,036,560 ) (Continued on the next page) |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R21NS124191 | Discovery of sensorimotor connectivity mechanisms in a continuous topographic map | 000 | 1 | NIH | 11/15/2022 | -$4,431 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R21AI169085 | Integrating T cell receptor features with gene expression profiles to define T cell specificity and differentiation | 000 | 1 | NIH | 10/14/2022 | -$1 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | K99NS121595 | Mechanisms of Target-Specific Axon Regeneration | 003 | 1 | NIH | 12/22/2022 | $0 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | K99NS121595 | Mechanisms of Target-Specific Axon Regeneration | 000 | 1 | NIH | 11/30/2022 | -$2,958 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 002 | 16 | NIH | 12/13/2022 | -$2,672,807 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 004 | 16 | NIH | 1/3/2023 | -$2,204,970 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068635 | SDMC: HIV Vaccine Trials Network | 002 | 16 | NIH | 12/19/2022 | $0 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 004 | 16 | NIH | 1/3/2023 | -$3,817,177 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01NS115974 | Membrane Curvature Sensing Mechanisms for Synaptic Vesicle Endocytosis | 003 | 3 | NIH | 11/28/2022 | -$28,853 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01NS115974 | Membrane Curvature Sensing Mechanisms for Synaptic Vesicle Endocytosis | 002 | 3 | NIH | 11/28/2022 | -$22,711 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068635 | SDMC: HIV Vaccine Trials Network | 002 | 16 | NIH | 12/19/2022 | $0 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 004 | 16 | NIH | 1/3/2023 | -$125,000 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01NS115974 | Membrane Curvature Sensing Mechanisms for Synaptic Vesicle Endocytosis | 001 | 3 | NIH | 11/28/2022 | -$89,755 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068635 | SDMC: HIV Vaccine Trials Network | 001 | 16 | NIH | 12/13/2022 | $0 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 004 | 16 | NIH | 1/3/2023 | -$125,000 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | F31CA260932 | Necrosis-mediated circulating tumor cell dissemination | 001 | 1 | NIH | 3/29/2023 | $0 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM133441 | Investigating chromatin mechanisms using viral systems | 002 | 3 | NIH | 11/8/2022 | -$31,925 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068635 | SDMC: HIV Vaccine Trials Network | 001 | 16 | NIH | 12/13/2022 | $0 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068635 | SDMC: HIV Vaccine Trials Network | 006 | 16 | NIH | 2/7/2023 | -$3,872,089 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068635 | SDMC: HIV Vaccine Trials Network | 006 | 16 | NIH | 2/7/2023 | -$1,564,038 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01NS119650 | Defining cellular states of quiescence in human brain tumors | 000 | 2 | NIH | 11/16/2022 | -$82,644 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068635 | SDMC: HIV Vaccine Trials Network | 000 | 16 | NIH | 11/30/2022 | -$241,853 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01HL148189 | Extrinsic regulation of primitive, myeloid-biased hematopoietic stem cells by Semaphorin 4a | 000 | 2 | NIH | 11/28/2022 | $0 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM119835 | Regulation of Protein Synthesis by Synonymous Codon Usage | 000 | 6 | NIH | 11/7/2022 | -$1,208 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM117446 | Origin firing at repetitive sequences and genome replication | 000 | 6 | NIH | 11/7/2022 | -$79,666 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM135362 | Selective mRNA translation in developmental disorders | 000 | 2 | NIH | 11/17/2022 | -$191,168 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | K99AI147029 | Quantifying the genetic and environmental factors driving avian influenza spillover | 000 | 2 | NIH | 1/3/2023 | -$51,230 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM105785 | Statistical Methods for RNA-seq Data Analysis | 000 | 8 | NIH | 11/4/2022 | -$75,376 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM124593 | Investigating how cellular mechanisms interface to maintain energy balance | 001 | 5 | NIH | 11/7/2022 | -$32,950 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM124593 | Investigating how cellular mechanisms interface to maintain energy balance | 000 | 5 | NIH | 11/7/2022 | -$110,880 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01NS115974 | Membrane Curvature Sensing Mechanisms for Synaptic Vesicle Endocytosis | 000 | 2 | NIH | 11/28/2022 | -$85,278 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UH3HL147011 | 1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis | 000 | 2 | NIH | 11/21/2022 | $0 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01NS115974 | Membrane Curvature Sensing Mechanisms for Synaptic Vesicle Endocytosis | 000 | 2 | NIH | 11/28/2022 | -$21,076 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R13OD024033 | Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference | 000 | 5 | NIH | 11/28/2022 | -$54,601 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 003 | 15 | NIH | 1/3/2023 | -$4,731,907 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R21TW012100 | The impact of HIV on the breast cancer tumor microenvironment | 000 | 1 | NIH | 12/13/2022 | $0 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM142728 | Regulation of Proteasome Capacity | 000 | 1 | NIH | 11/7/2022 | -$1,662 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM133441 | Investigating chromatin mechanisms using viral systems | 001 | 3 | NIH | 11/8/2022 | -$507 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM133441 | Investigating chromatin mechanisms using viral systems | 001 | 3 | NIH | 11/8/2022 | -$852 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01AI123323 | Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity | 000 | 5 | NIH | 12/8/2022 | -$20,509 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 003 | 15 | NIH | 1/3/2023 | -$1,603,673 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM143186 | Cellular mechanisms of nucleocytoplasmic export through Nuclear Envelope Budding | 000 | 1 | NIH | 11/7/2022 | $0 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | K99DE030194 | Targeting the DNA Damage Response in HPV+ Head and Neck Cancer | 000 | 1 | NIH | 11/10/2022 | -$1,470 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM133441 | Investigating chromatin mechanisms using viral systems | 000 | 3 | NIH | 11/8/2022 | -$3,443 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | F99CA245735 | Profiling and leveraging bystander T cells within the tumor microenvironment | 002 | 2 | NIH | 1/19/2023 | -$253 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 003 | 15 | NIH | 1/3/2023 | -$4,027,456 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM141457 | Molecular modeling and machine learning for protein structures and interactions | 000 | 1 | NIH | 11/7/2022 | $0 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01CA236558 | Statistical Methods for Prospective Evaluation of Biomarkers | 000 | 11 | NIH | 10/1/2022 | -$27,120 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068635 | SDMC: HIV Vaccine Trials Network | 005 | 15 | NIH | 2/7/2023 | -$502,458 |
|
